Cargando…

Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?

OBJECTIVE: Doses of gonadotropin releasing hormone (GnRH) analogues used to treat idiopathic central precocious puberty (iCPP) vary among clinicians. Study aims were to evaluate the efficacy of a monthly 3.75 mg dose of leuprolide acetate (LA) to suppress the hypothalamo-pituitary-gonadal (HPG) axis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vurallı, Doğuş, Alikaşifoğlu, Ayfer, İyigün, İrem, Canoruç, Dicle, Ozon, Alev, Gönç, Nazlı, Kandemir, Nurgün
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7127887/ https://www.ncbi.nlm.nih.gov/pubmed/31347350 http://dx.doi.org/10.4274/jcrpe.galenos.2019.2019.0060

Ejemplares similares

Central nervous system imaging in girls with central precocious puberty: when is necessary?
por: Vuralli, Dogus, et al.
Publicado: (2020)

Adequacy of basal luteinizing hormone levels in the diagnosis of central precocious puberty
por: Vurallı, Doğuş, et al.
Publicado: (2020)

GnRH Stimulation Test in Precocious Puberty: Single Sample is Adequate for Diagnosis and Dose Adjustment
por: Kandemir, Nurgün, et al.
Publicado: (2011)

Severe Undervirilisation in a 46,XY Case Due to a Novel Mutation in HSD17B3 Gene
por: Alikaşifoğlu, Ayfer, et al.
Publicado: (2015)

Growth Hormone Deficiency in a Child with Neurofibromatosis-Noonan Syndrome
por: Vurallı, Doğuş, et al.
Publicado: (2016)

Long-Term Follow-up of a Case with Proprotein Convertase 1/3 Deficiency: Transient Diabetes Mellitus with Intervening Diabetic Ketoacidosis During Growth Hormone Therapy
por: Gönç, E. Nazlı, et al.
Publicado: (2017)

The Relationship Between Serum Adiponectin, Tumor Necrosis Factor−Alpha, Leptin Levels and Insulin Sensitivity in Childhood and Adolescent Obesity: Adiponectin is a Marker of Metabolic Syndrome
por: Alikaşifoğlu, Ayfer, et al.
Publicado: (2009)

Need for Comprehensive Hormonal Workup in the Management of Adrenocortical Tumors in Children
por: Gönç, E. Nazlı, et al.
Publicado: (2014)

Basal Serum Thyroxine Level should Guide Initial Thyroxine Replacement Dose in Neonates with Congenital Hypothyroidism
por: Günbey, Ceren, et al.
Publicado: (2021)

Feminizing Adrenocortical Tumors as a Rare Etiology of Isosexual/Contrasexual Pseudopuberty
por: Vurallı, Doğuş, et al.
Publicado: (2022)

Hyperthyroidism After Allogeneic Hematopoietic Stem Cell Transplantation: A Report of Four Cases
por: Sağ, Erdal, et al.
Publicado: (2015)

Hyperinsulinism May Be Underreported in Hypoglycemic Patients with Phosphomannomutase 2 Deficiency
por: Vurallı, Doğuş, et al.
Publicado: (2022)

Challenges During the Coronavirus Disease 2019 Pandemic: Diabetes Control and Psychosocial Issues in Children with Type 1 Diabetes Mellitus and Their Mothers
por: Canoruç Emet, Dicle, et al.
Publicado: (2023)

Leuprolide Acetate 1-Month Depot for Central Precocious Puberty: Hormonal Suppression and Recovery
por: Neely, E. Kirk, et al.
Publicado: (2010)

Psychosocial Impact of the COVID-19 Pandemic on Children with Congenital Adrenal Hyperplasia and Their Families
por: Berna Çelik, Nur, et al.
Publicado: (2022)

Multicenter clinical trial of leuprolide acetate depot (Luphere depot 3.75 mg) for efficacy and safety in girls with central precocious puberty
por: Kim, You Jin, et al.
Publicado: (2013)

Pseudotumor cerebri in patient on leuprolide acetate for central precocious puberty
por: Omar, Anjumanara Anver, et al.
Publicado: (2020)

Efficacy and Safety of Leuprolide Acetate 6-Month Depot for the Treatment of Central Precocious Puberty: A Phase 3 Study
por: Klein, Karen O, et al.
Publicado: (2023)

Hypophosphatasia Presenting with Pyridoxine-Responsive Seizures, Hypercalcemia, and Pseudotumor Cerebri: Case Report
por: Demirbilek, Hüseyin, et al.
Publicado: (2012)

Efficacy of Leuprolide Acetate 1-Month Depot for Central Precocious Puberty (CPP): Growth Outcomes During a Prospective, Longitudinal Study
por: Lee, Peter A, et al.
Publicado: (2011)

6-Month Subcutaneous Leuprolide Acetate Effectively Suppresses Clinical Signs of Puberty in Children With Central Precocious Puberty
por: Eugster, Erica A, et al.
Publicado: (2021)

Leuprolide and triptorelin treatment in children with idiopathic central precocious puberty: an efficacy/tolerability comparison study
por: Valenzise, M., et al.
Publicado: (2023)

Clinical development of the GnRH agonist leuprolide acetate depot
por: Chwalisz, Kristof
Publicado: (2022)

Phase 3 Trial of a Small-volume Subcutaneous 6-Month Duration Leuprolide Acetate Treatment for Central Precocious Puberty
por: Klein, Karen O, et al.
Publicado: (2020)

The effect of triptorelin and leuprolide on the level of sex hormones in girls with central precocious puberty and its clinical efficacy analysis
por: Wang, Lan, et al.
Publicado: (2021)

Elevated Random Luteinizing Hormone is an Unreliable Indicator for Pubertal Suppression in Girls Treated with Monthly Leuprolide for Idiopathic Central Precocious Puberty
por: Wiromrat, Pattara, et al.
Publicado: (2019)

ODP397 Small-volume, Subcutaneous, 6-month Leuprolide Acetate Effectively Reduces Growth Velocity to Prepubertal Levels in Children with Central Precocious Puberty
por: Klein, Karen O, et al.
Publicado: (2022)

THU195 6-Month Subcutaneous Leuprolide Acetate Achieved And Maintained Hormonal And Clinical Suppression In All Weight Groups Of Children With Central Precocious Puberty
por: Miller, Bradley S, et al.
Publicado: (2023)

Efficacy and safety of leuprolide acetate 6-month depot for suppression of testosterone in patients with prostate cancer
por: Spitz, A, et al.
Publicado: (2012)

Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center
por: Chung, Lindsey Yoojin, et al.
Publicado: (2021)

Precocious puberty in girls
por: Chittwar, Sachin, et al.
Publicado: (2012)

Precocious puberty in children
por: Atta, Irum, et al.
Publicado: (2013)

Management of precocious puberty
por: Tanaka, Toshiaki
Publicado: (2013)

Hepatoblastoma with Precocious Puberty
por: Yhoshu, Enono, et al.
Publicado: (2019)

Pelvic Ultrasound Parameters of Long-Acting Depot Formulation of Leuprorelin in the Treatment of Idiopathic Central Precocious Puberty in Girls
por: Yang, Kun, et al.
Publicado: (2021)

Transient central precocious puberty: a new entity among the spectrum of precocious puberty?
por: Assirelli, Valentina, et al.
Publicado: (2021)

Contemporary issues in precocious puberty
por: Bajpai, Anurag, et al.
Publicado: (2011)

The characteristics of familial precocious puberty
por: Jeong, Hwal Rim, et al.
Publicado: (2015)

Treatment of Central Precocious Puberty
por: Eugster, Erica A
Publicado: (2019)

Genetic factors in precocious puberty
por: Shim, Young Suk, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2qqaqqh9sdbs7j9e7vh4jjqjaq